Updated Date: Thu, 29 Dec 2022 00:00:00 EST

Updated Date: Thu, 29 Dec 2022 00:00:00 EST

Updated Date: Thu, 29 Dec 2022 00:00:00 EST

Safety, tolerability and pharmacokinetic endpoints for MTX652 have been successfully met

Agreement covers cell-based studies, with an additional option to further develop screening activities

Research has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that […]

With a shortage of therapists, help with mental health problems is being sought from digital interventions, where elements […]

With a multimodal microscope, the Laser Zentrum Hannover e.V. (LZH) and three partners in the joint project PriMe […]

Updated Date: Wed, 28 Dec 2022 00:00:00 EST

Updated Date: Wed, 28 Dec 2022 00:00:00 EST